Rising drug prices were in the spotlight as pharmaceutical industry executives testifed before the Senate Finance Committee on Tuesday.
Lawmakers questioned executives from firms such as Merck & Co. and Pfizer Inc. about their pricing practices and methods of thwarting competition from lower-cost generic rivals.
Sen. Chuck Grassley (R., Iowa), the committee chairman, warned CEOs ahead of the hearing not to “try to blame everyone but themselves.”Here’s an article previewing the hearing.
And here’s how the hearing unfolded:...